Stockreport

Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement [Yahoo! Finance]

Salarius Pharmaceuticals, Inc.  (SLRX) 
PDF Company) announces that on September 4, 2025 the Company received notification from The Nasdaq Stock Market LLC (Nasdaq) that it has regained compliance with Listing Rul [Read more]